Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes

Documenti analoghi

• Reduced prandial insulin secretion contributes to prandial hyperglycaemia in non‐diabetic individuals with spinal cord injury
  di: Michelle Trbovich, et al.
  Pubblicazione: (2025)
• Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes
  di: Ying Wei, et al.
  Pubblicazione: (2026)
• An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes
  di: Geremia B. Bolli, et al.
  Pubblicazione: (2025)
• Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
  di: Jiaqiang Zhang, et al.
  Pubblicazione: (2025)
• Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline HbA1c , BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1–5
  di: Alice Y. Y. Cheng, et al.
  Pubblicazione: (2025)